Pulmonary Arterial Hypertension

The Maine Pulmonary Hypertension Program at CMA and MMC is devoted to providing thorough evaluation, treatment, and follow-up for patients with primary and secondary pulmonary hypertension.

Pulmonary hypertension, a disease characterized by an abnormal elevation of the blood pressure within the pulmonary blood vessels, has many effective treatments, but no cure. Patients generally have exercise intolerance, which may be associated with progressive shortness of breath, palpitations, lightheaded spells, chest discomfort, or ankle swelling.

Pulmonary hypertension patients may be seen and evaluated on an inpatient basis at Maine Medical Center in Portland or as an outpatient at the Chest Medicine Associates' office in South Portland. The Pulmonary Hypertension Program serves patients with pulmonary hypertension from throughout Northern New England.

A complete evaluation of patients with pulmonary hypertension is required to provide the optimal treatment to each individual. Diagnostic services offered include experienced pulmonary, cardiology, rheumatology, endocrinology and hepatology consultation as necessary, echocardiography (transthoracic and transesophageal), ventilation-perfusion lung scanning, pulmonary function testing, sleep and cardiopulmonary exercise testing, pulmonary angiography, chest computed tomography scanning, and direct hemodynamic/vasodilator assessments.

Chest Medicine Associates also participates in several clinical research trials for pulmonary arterial hypertension (PAH).